AstraZeneca has agreed to acquire U.S.-based vaccine developer Icosavax for $1.1 billion, the companies announced Tuesday, to gain access to experimental vaccines targeting common respiratory ...

The pharmaceutical giant AstraZeneca on Tuesday said it is withdrawing its COVID-19 vaccine worldwide due to low demand and following reports that the vaccine caused rare side effects.

AstraZeneca has started to pull its Covid-19 vaccine from global markets because of low demand, the pharmaceutical giant said. The decision closes the chapter on a shot that was widely used in the ...

But the vaccine has not generated revenue for AstraZeneca since April 2023, the company said. “As multiple, variant Covid-19 vaccines have … been developed, there is a surplus of available ...

AstraZeneca, which is withdrawing its COVID-19 vaccine, says independent estimates show that it saved over 6.5 million lives in the first year of its use.

AstraZeneca Wednesday said it was pulling its Vaxzevria COVID-19 vaccine pictured here from sale globally for commercial reasons. The company has admitted in Britain's High Court that in rare ...

The AstraZeneca vaccine has been one of the main COVID-19 vaccines worldwide, with more than 3 billion doses supplied since 2021. Skip to content. NOWCAST WLWT News 5 at 10:00.